Results 161 to 170 of about 115,857 (253)
ABSTRACT Intact antigen presentation in cancer cells is a key prerequisite for endogenous anticancer T cell responses and a starting point for immunotherapy. Calreticulin was postulated as a chaperone and integral part of the peptide‐loading complex of MHC‐I.
Maria Höhrhan +8 more
wiley +1 more source
Genomic Medicine Sweden: Advancing precision medicine at the national level
Abstract High‐throughput sequencing has transformed clinical diagnostics of rare diseases (RD), cancer and infectious diseases by enabling the identification of disease‐causing genetic alterations and facilitating individualised treatment and care.
Anders Edsjö +58 more
wiley +1 more source
Epigenetic Rewiring and Context-Dependent Therapeutic Vulnerabilities in Myeloproliferative Neoplasms. [PDF]
Abdelgawwad El-Sehrawy AAM +7 more
europepmc +1 more source
ABSTRACT Background and Aims Assessing liver congestion and portal hypertension (PHT) in Budd–Chiari syndrome (BCS) remains challenging. We evaluated liver and spleen stiffness measurements (LSM, SSM) obtained by transient elastography as non‐invasive tools for identifying clinically meaningful liver congestion in BCS.
Andreea Fodor +22 more
wiley +1 more source
Are Myeloproliferative Neoplasms-Unclassifiable Really Unclassifiable? [PDF]
Barosi G, Rosti V, Gale RP.
europepmc +1 more source
Clinical management of clonal hematopoiesis
ABSTRACT Clonal hematopoiesis, particularly clonal hematopoiesis of indeterminate potential and clonal cytopenia of undetermined significance, is an age‐related premalignant condition characterized by the expansion of hematopoietic clones carrying somatic mutations.
Kelly S. Chien +1 more
wiley +1 more source
Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms. [PDF]
Hertz C +7 more
europepmc +1 more source
Ophthalmological and epidemiological profiles of Brazilian patients with philadelphia-negative Myeloproliferative neoplasms. [PDF]
Piloni-Parreira R +7 more
europepmc +1 more source
Increased glioblastoma risk in patients with myeloproliferative neoplasms and myelodysplastic syndromes. [PDF]
Zhou H, Jin S, Huang L, Liu W.
europepmc +1 more source
Genomic characterization of spleens in patients with myelofibrosis
Eran Zimran +6 more
doaj +1 more source

